Yahoo
OTC Markets OTCPK - Delayed Quote USD

Glanbia plc (GLAPF)

23.15 0.00 (0.00%)
At close: October 30 at 4:00:00 PM EDT
GLAPF Q3 2026 earnings call
November 4, 2026 at 3:30 AM EST
Chart Range Bar
Loading chart for GLAPF
  • Previous Close 23.15
  • Open 24.31
  • Bid 23.77 x 10000
  • Ask 24.23 x 20000
  • Day's Range 24.31 - 24.31
  • 52 Week Range 15.99 - 28.81
  • Volume 2
  • Avg. Volume 529
  • Market Cap (intraday) 5.595B
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 23.87
  • EPS (TTM) 0.97
  • Earnings Date Aug 6, 2026
  • Forward Dividend & Yield 0.51 (2.22%)
  • Ex-Dividend Date Aug 20, 2026
  • 1y Target Est --

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

www.glanbia.com

4,963

Full Time Employees

January 03

Fiscal Year Ends

Packaged Foods

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is ISEQ All Share (^ISEQ) .

YTD Return

GLAPF
38.23%
ISEQ All Share (^ISEQ)
8.83%

1-Year Return

GLAPF
39.87%
ISEQ All Share (^ISEQ)
20.26%

3-Year Return

GLAPF
65.51%
ISEQ All Share (^ISEQ)
79.30%

5-Year Return

GLAPF
64.27%
ISEQ All Share (^ISEQ)
65.79%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.80%

  • Return on Assets (ttm)

    6.22%

  • Return on Equity (ttm)

    12.05%

  • Revenue (ttm)

    4.1B

  • Net Income Avi to Common (ttm)

    237.7M

  • Diluted EPS (ttm)

    0.97

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    375.7M

  • Total Debt/Equity (mrq)

    63.69%

  • Levered Free Cash Flow (ttm)

    335.58M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: